
Under The Scrubs
Where medical meets conversation and we discuss stories, news, evidence based practice, true crime, and more.
Under The Scrubs
Oh Oh Oh Ozempic
In this episode, Hannah dives deep into Ozempic, Wegovy, and other GLP-1 receptor agonists, the groundbreaking medications transforming weight loss and type 2 diabetes management. We explore how GLP-1 drugs work, their benefits, side effects, and the latest research on their impact beyond diabetes—the good, the bad, and the ugly. We also look into the lawsuits that are being brought up and might threaten the future of the medication.
Join us as we break down the science behind semaglutide and similar medications, discuss who might benefit from them, and explore alternative methods when it comes to weight loss. Whether you're considering Ozempic for weight loss, curious about long-term effects, or just want to stay informed on the latest diabetes treatments, this episode has you covered!
Resources:
https://www.news-medical.net/health/How-Does-Semaglutide-Work-to-Lose-Weight.aspx
https://pmc.ncbi.nlm.nih.gov/articles/PMC5397288/
https://www.nejm.org/doi/10.1056/NEJMoa2032183
https://www.medpagetoday.com/special-reports/exclusives/112138
https://www.nbcnews.com/news/remi-bader-shares-ozempic-experience-rcna65527
https://www.healthline.com/health-news/ozempic-muscle-mass-loss
https://www.insurance.ca.gov/0400-news/0100-press-releases/archives/release088-17.cfm
https://www.lawsuit-information-center.com/ozempic-gastroparesis-lawsuit.html
https://www.insurance.ca.gov/0400-news/0100-press-releases/archives/release088-17.cfm
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822453
https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/2829462
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820255
https://www.mayoclinic.org/healthy-lifestyle/weight-loss/expert-answers/phentermine/faq-20057940
https://pmc.ncbi.nlm.nih.gov/articles/PMC8314402/#sec4
https://pmc.ncbi.nlm.nih.gov/articles/PM
Follow us @underthescrubspodcast on IG!